This randomized trial investigates the effects of bisphenols and atrazine on hormonal responses in fish liver cells, indicating potential endocrine disruption.
Primary hepatocytes isolated from Oreochromis niloticus were cultured under different serum media supplementation to establish the least stressful culturing conditions. Host-derived serum provided the highest metabolic support and the lowest cytotoxicity, outperforming the commonly used fetal bovine serum. Some non-host sera were toxic at 10% concentration but tolerable or even beneficial at 5% concentration. Separately, the primary hepatocytes were exposed to endocrine-disrupting chemicals (EDCs) and in vitro vitellogenin levels were measured after exposure to effective concentrations identified through estrogen receptor molecular docking analysis. The analysis predicted the strongest affinity for estradiol, bisphenol A and bisphenol S, whereas atrazine and its metabolites showed much weaker binding. After 48 h of exposure, except for estradiol, all of the compounds tested did not significantly induce vitellogenin secretion. However, transcriptional activation of the estrogen receptor was observed for both bisphenols and estradiol, but not for atrazine and its metabolites. Further assays of testosterone conversion to 11-ketotestosterone under exposure to the tested EDCs revealed a major impairment in conversion in the presence of atrazine. As such, it is concluded that some EDCs may fail to activate the estrogen receptor and induce VTG in vitro while still exerting endocrine-disrupting effects through the impairment of testosterone conversion to its more potent metabolite.
No takes yet. Share an insight, caveat, or question.
Pop et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: